Xponance Inc. Has $84,000 Stock Holdings in Clarivate Plc (NYSE:CLVT)

Xponance Inc. decreased its position in Clarivate Plc (NYSE:CLVT) by 11.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,830 shares of the company’s stock after selling 1,919 shares during the period. Xponance Inc.’s holdings in Clarivate were worth $84,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Baupost Group LLC MA lifted its position in Clarivate by 27.2% in the second quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock worth $221,510,000 after purchasing an additional 8,331,233 shares during the period. Glenview Capital Management LLC lifted its holdings in shares of Clarivate by 22.2% during the 4th quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock worth $228,269,000 after acquiring an additional 4,472,302 shares during the period. Capital World Investors bought a new position in shares of Clarivate during the 1st quarter worth about $30,104,000. Confluence Investment Management LLC acquired a new stake in shares of Clarivate during the 1st quarter valued at about $18,389,000. Finally, Dimensional Fund Advisors LP increased its stake in Clarivate by 19.5% in the second quarter. Dimensional Fund Advisors LP now owns 14,752,994 shares of the company’s stock valued at $83,945,000 after acquiring an additional 2,409,470 shares during the period. Institutional investors own 85.72% of the company’s stock.

Insiders Place Their Bets

In related news, Director Andrew Miles Snyder purchased 28,938 shares of the stock in a transaction that occurred on Thursday, August 8th. The stock was acquired at an average price of $5.49 per share, with a total value of $158,869.62. Following the completion of the acquisition, the director now directly owns 288,334 shares in the company, valued at approximately $1,582,953.66. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Clarivate news, insider Bar Veinstein sold 120,000 shares of the business’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $7.00, for a total transaction of $840,000.00. Following the completion of the sale, the insider now directly owns 976,583 shares of the company’s stock, valued at approximately $6,836,081. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrew Miles Snyder bought 28,938 shares of Clarivate stock in a transaction dated Thursday, August 8th. The stock was acquired at an average cost of $5.49 per share, for a total transaction of $158,869.62. Following the purchase, the director now directly owns 288,334 shares in the company, valued at approximately $1,582,953.66. The disclosure for this purchase can be found here. Insiders own 22.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Royal Bank of Canada decreased their price objective on Clarivate from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Wednesday, August 7th. Barclays lowered their price target on Clarivate from $6.00 to $5.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Clarivate presently has an average rating of “Hold” and a consensus price target of $7.71.

Clarivate Trading Up 2.3 %

CLVT stock opened at $6.74 on Thursday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.90 and a quick ratio of 0.90. The stock has a market capitalization of $4.50 billion, a price-to-earnings ratio of -4.06 and a beta of 1.17. The business has a fifty day moving average price of $6.53 and a 200 day moving average price of $6.43. Clarivate Plc has a fifty-two week low of $4.97 and a fifty-two week high of $9.60.

Clarivate (NYSE:CLVT) last announced its earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $650.30 million during the quarter, compared to analyst estimates of $651.94 million. Clarivate had a positive return on equity of 10.01% and a negative net margin of 46.53%. The firm’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same period last year, the company posted $0.16 earnings per share. Analysts expect that Clarivate Plc will post 0.64 EPS for the current fiscal year.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.